NYSE:GKOSMedical Equipment
A Look At Glaukos (GKOS) Valuation After Raised 2026 Sales Guidance And Strong First Quarter Revenue
Glaukos (GKOS) is back in focus after raising its 2026 net sales guidance to a range of US$620 million to US$635 million and reporting first quarter sales of US$150.57 million.
See our latest analysis for Glaukos.
The stock has recently pulled back 3.1% on a 1-day share price return, but that comes after a 22.7% year to date share price return and a 56.4% 1-year total shareholder return. This suggests momentum has been building around the updated guidance and first quarter revenue figures.
If...